Benzinga | Feb 25, 2021 07:59AM EST

Intellia Therapeutics Q4 EPS $(0.69) Misses $(0.60) Estimate, Sales $6.59M Miss $14.09M Estimate

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.60) by 15 percent. This is a 21.05 percent decrease over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $6.59 million which missed the analyst consensus estimate of $14.09 million by 53.19 percent. This is a 39.69 percent decrease over sales of $10.94 million the same period last year.